Revisions of Previously Issued Financial Statements (Details) - USD ($) |
3 Months Ended | 6 Months Ended | 9 Months Ended | ||||
---|---|---|---|---|---|---|---|
Sep. 30, 2020 |
Mar. 31, 2020 |
Dec. 31, 2019 |
Sep. 30, 2019 |
Dec. 31, 2019 |
Mar. 31, 2020 |
Jun. 30, 2020 |
|
Total assets | $ 81,334,782 | $ 58,529,619 | |||||
Total liabilities | 23,613,226 | 21,955,213 | |||||
Total stockholders' equity | 57,721,556 | $ 31,870,154 | |||||
Cost of revenue | $ 1,396,219 | $ 1,615,239 | $ 1,379,701 | $ 2,994,940 | $ 4,391,159 | ||
Gross profit | 1,674,327 | 1,690,964 | 1,813,189 | 3,504,153 | 5,178,480 | ||
Product development | 1,758,826 | 874,787 | 623,501 | 610,902 | 1,234,403 | 2,109,190 | |
Selling, general and administrative | 5,678,242 | 4,883,172 | 3,601,714 | 8,484,886 | 14,163,128 | ||
Operating expenses | $ 7,497,537 | 4,212,616 | |||||
Net loss | $ (4,744,129) | $ (3,763,695) | $ (2,326,332) | $ (6,090,027) | $ (10,834,156) | ||
Net loss per share | $ (0.34) | $ (0.38) | $ (0.34) | $ (0.21) | $ (0.56) | $ (0.96) | |
As Reported [Member] | |||||||
Cost of revenue | $ 1,420,909 | $ 1,638,840 | $ 1,397,361 | $ 3,036,201 | $ 4,457,110 | ||
Gross profit | 1,649,637 | 1,667,363 | 1,795,529 | 3,462,892 | 5,112,529 | ||
Product development | 1,632,353 | 1,261,509 | 1,130,880 | 2,392,389 | 4,024,742 | ||
Selling, general and administrative | 5,500,837 | 4,796,404 | 3,583,815 | 8,380,219 | 13,881,056 | ||
Net loss | $ (5,348,980) | $ (4,338,536) | $ (2,846,071) | $ (7,184,607) | $ (12,533,587) | ||
Net loss per share | $ (0.43) | $ (0.40) | $ (0.26) | $ (0.66) | $ (1.11) | ||
Adjustment [Member] | |||||||
Cost of revenue | $ (24,690) | $ (23,601) | $ (17,660) | $ (41,261) | $ (65,951) | ||
Gross profit | 24,690 | 23,601 | 17,660 | 41,261 | 65,951 | ||
Product development | (757,566) | (638,008) | (519,978) | (1,157,986) | (1,915,552) | ||
Selling, general and administrative | 177,405 | 86,768 | 17,899 | 104,667 | 282,072 | ||
Net loss | $ 604,851 | $ 574,841 | $ 519,739 | $ 1,094,580 | $ 1,699,431 | ||
Net loss per share |
X | ||||||||||
- Definition The aggregates cost of goods produced and sold and services rendered during the reporting period. No definition available.
|
X | ||||||||||
- Definition Aggregate revenue less cost of goods and services sold or operating expenses directly attributable to the revenue generation activities. No definition available.
|
X | ||||||||||
- Definition Net loss. No definition available.
|
X | ||||||||||
- Definition Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
X | ||||||||||
- Definition The amount of net income or loss for the period per each share in instances when basic and diluted earnings per share are the same amount and reported as a single line item on the face of the financial statements. Basic earnings per share is the amount of net income or loss for the period per each share of common stock or unit outstanding during the reporting period. Diluted earnings per share includes the amount of net income or loss for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
X | ||||||||||
- Definition Sum of the carrying amounts as of the balance sheet date of all liabilities that are recognized. Liabilities are probable future sacrifices of economic benefits arising from present obligations of an entity to transfer assets or provide services to other entities in the future. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
X | ||||||||||
- Definition Generally recurring costs associated with normal operations except for the portion of these expenses which can be clearly related to production and included in cost of sales or services. Includes selling, general and administrative expense. No definition available.
|
X | ||||||||||
- Definition The aggregate costs incurred (1) in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or (2) to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process whether intended for sale or the entity's use, during the reporting period charged to research and development projects, including the costs of developing computer software up to the point in time of achieving technological feasibility, and costs allocated in accounting for a business combination to in-process projects deemed to have no alternative future use. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
X | ||||||||||
- Definition The aggregate total costs related to selling a firm's product and services, as well as all other general and administrative expenses. Direct selling expenses (for example, credit, warranty, and advertising) are expenses that can be directly linked to the sale of specific products. Indirect selling expenses are expenses that cannot be directly linked to the sale of specific products, for example telephone expenses, Internet, and postal charges. General and administrative expenses include salaries of non-sales personnel, rent, utilities, communication, etc. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
X | ||||||||||
- Definition Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
X | ||||||||||
- Details
|
X | ||||||||||
- Details
|